Anti ColQ fused with the transmembrane domain of contactin-associated protein-like 2 (CASPR2) in CBAs have detected ColQAbs in 3% of MG patients, although similar frequencies are reported in the controls (76, 77). This evidence concerns the gene COLQ and myasthenia gravis.